Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process

Journal of Clinical Medicine

Alfredo García-Layana¹  Caroline C. W. Klaver²  Gerhard Garhöfer³  Johanna M. Seddon⁴  Rufino Silva⁵  Tariq M. Aslam⁶  Angelo M. Minnella⁷  Cécile Delcourt⁸ 

[1] Clínica Universidad de Navarra, IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31009 Pamplona, Spain;Department Ophthalmology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands;Department of Clinical Pharmacology, Medical University of Vienna, 1090 Wien, Austria;Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA 01655, USA;Faculty of Medicine, Institute for Clinical and Biomedical Research (ICBR-FMUC), University of Coimbra, 3000-548 Coimbra, Portugal;School of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK;UOC Oculistica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy;University Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, F-33000 Bordeaux, France;

关键词: age-related macular degeneration;    prevention;    identification;    risk;    Delphi;    STARS^®;   

DOI  :  10.3390/jcm10225432

来源: DOAJ

【 摘 要 】

Background: Early identification of AMD can lead to prompt and more effective treatment, better outcomes, and better final visual acuity; several risk scores have been devised to determine the individual level of risk for developing AMD. Herein, the Delphi method was used to provide recommendations for daily practice regarding preventive measures and follow-up required for subjects at low, moderate, and high risk of AMD evaluated with the Simplified Test AMD Risk-assessment Scale (STARS^®) questionnaire. Methods: A steering committee of three experts drafted and refined 25 statements on the approach to be recommended in different clinical situations [general recommendations (n = 2), use of evaluation tools (n = 4), general lifestyle advice (n = 3), and AREDS-based nutritional supplementation (n = 5)] with the help of a group of international experts, all co-authors of this paper. Thirty retinal specialists from Europe and the US were chosen based on relevant publications, clinical expertise, and experience in AMD, who then provided their level of agreement with the statements. Statements for which consensus was not reached were modified and voted upon again. Results: In the first round of voting, consensus was reached for 24 statements. After modification, consensus was then reached for the remaining statement. Conclusion: An interprofessional guideline to support preventive measures in patients at risk of AMD based on STARS^® scoring has been developed to aid clinicians in daily practice, which will help to optimize preventive care of patients at risk of AMD.

【 授权许可】

Unknown